Category Archives for "News"

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank November 23, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 23, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of Select Strains Inc. (“Select Strains”). […]

Read More

Abattis Bioceuticals Retains Canadian and American Compliance Agency and Provides Company Update

Abattis Retains Canadian and American Compliance Agency and Provides Company Update November 20, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 20, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient Identity LLC (“Ingredient Identity”), a Canadian and US regulatory and compliance […]

Read More

Abattis Bioceuticals Celebrates Legalization

Abattis Bioceuticals Celebrates Legalization October 17, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / [October 17, 2018] / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a truly a newsworthy day in Canadian history, as we formally recognize the end […]

Read More

Abattis Bioceuticals Announces Board Changes

Abattis Bioceuticals Announces Board Change October 19, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / October 19, 2018 / Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to announce the addition of Kent McParland and Cedric Wilson to the Board of Directors. Mr. McParland and Mr. Wilson replace Cameron Paddock […]

Read More

Abattis Bioceuticals provides Update on Vaporizer Product Line

ABATTIS BIOCEUTICALS PROVIDES UPDATE ON VAPORIZER PRODUCT LINE October 11, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce an update on our recent product line addition of three new vaporizers. Currently, the VB-1, VB-2, CA-2 and the KB-1 have now been made available for purchase […]

Read More

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil October 4, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the research being done in conjunction with the University of British Columbia and Mitacs […]

Read More